Cargando…
Determination of Dabigatran Concentration in Human Plasma and Breast Milk
Venous thromboembolism (VTE) is an important cause of death following childbirth. Dabigatran etexilate can be a useful prophylaxis in susceptible women during the postpartum period. However, it is not clear whether dabigatran is excreted into breast milk in amounts which can be harmful to the suckli...
Autores principales: | Sidgwick, F., Porter, A., Ayuk, P., Kamali, F., Truemann, A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8556115/ https://www.ncbi.nlm.nih.gov/pubmed/34721581 http://dx.doi.org/10.1155/2021/5949385 |
Ejemplares similares
-
Delayed concentration effect models for dabigatran anticoagulation
por: Eaton, Michael P., et al.
Publicado: (2022) -
Correlation Between Trough Plasma Dabigatran Concentrations and Estimates of Glomerular Filtration Rate Based on Creatinine and Cystatin C
por: Chin, Paul K. L., et al.
Publicado: (2014) -
The Effect of Oral L-cysteine on Breast Milk and Plasma Cysteine Concentrations
por: Dowlati, Yekta, et al.
Publicado: (2020) -
Dabigatran Acylglucuronide, the Major Metabolite of Dabigatran, Shows a Weaker Anticoagulant Effect than Dabigatran
por: Kim, Jong-Min, et al.
Publicado: (2022) -
The Dabigatran debate
por: Kaba, Riyaz A, et al.
Publicado: (2014)